Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Tufman

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Future Oncology (London, England)|January 13, 2022
Lymphocytes and sinus histiocytosis in tumor and matched lymph nodes as predictors of survival in non-small-cell lung cancerLaura Sellmer, Julia Kovács, Jens Neumann, et al.
Infection|October 9, 2021
One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patientFelix Endres, Judith Eva Spiro, Toki Anna Bolt, et al.
Respirology (Carlton, Vic.)|April 5, 2014
Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitorsGregor S Zimmermann, Werner von Wulffen, Patrick Huppmann, et al.
Translational Lung Cancer Research|July 18, 2020
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapyOlarn Roengvoraphoj, Lukas Käsmann, Chukwuka Eze, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2023
Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practiceJulia Walter, Caroline Moeller, Blerina Resuli, et al.
Investigational New Drugs|August 5, 2021
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibitionJulian Taugner, Lukas Käsmann, Monika Karin, et al.
Radiation Oncology (London, England)|January 4, 2020
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapyKathrin Gennen, Lukas Käsmann, Julian Taugner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Clinical Medicine Insights. Oncology|September 30, 2022
Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient-Reported Experiences During the COVID-19 PandemicToki Bolt, Amanda Tufman, Laura Sellmer, et al.
International Journal of Biometeorology|February 9, 2011
Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, GermanyUta Ferrari, Teresa Exner, Eva R Wanka, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Future Oncology (London, England)|January 13, 2022
Lymphocytes and sinus histiocytosis in tumor and matched lymph nodes as predictors of survival in non-small-cell lung cancerLaura Sellmer, Julia Kovács, Jens Neumann, et al.
Infection|October 9, 2021
One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patientFelix Endres, Judith Eva Spiro, Toki Anna Bolt, et al.
Respirology (Carlton, Vic.)|April 5, 2014
Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitorsGregor S Zimmermann, Werner von Wulffen, Patrick Huppmann, et al.
Translational Lung Cancer Research|July 18, 2020
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapyOlarn Roengvoraphoj, Lukas Käsmann, Chukwuka Eze, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2023
Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practiceJulia Walter, Caroline Moeller, Blerina Resuli, et al.
Investigational New Drugs|August 5, 2021
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibitionJulian Taugner, Lukas Käsmann, Monika Karin, et al.
Radiation Oncology (London, England)|January 4, 2020
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapyKathrin Gennen, Lukas Käsmann, Julian Taugner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Clinical Medicine Insights. Oncology|September 30, 2022
Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient-Reported Experiences During the COVID-19 PandemicToki Bolt, Amanda Tufman, Laura Sellmer, et al.
International Journal of Biometeorology|February 9, 2011
Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, GermanyUta Ferrari, Teresa Exner, Eva R Wanka, et al.
Pageof 15